Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials.

Ellingson BM, Harris RJ, Woodworth DC, Leu K, Zaw O, Mason WP, Sahebjam S, Abrey LE, Aftab DT, Schwab GM, Hessel C, Lai A, Nghiemphu PL, Pope WB, Wen PY, Cloughesy TF.

Neuro Oncol. 2017 Jan;19(1):89-98. doi: 10.1093/neuonc/now187.

2.

Residual Tumor Volume as Best Outcome Predictor in Low Grade Glioma - A Nine-Years Near-Randomized Survey of Surgery vs. Biopsy.

Roelz R, Strohmaier D, Jabbarli R, Kraeutle R, Egger K, Coenen VA, Weyerbrock A, Reinacher PC.

Sci Rep. 2016 Aug 30;6:32286. doi: 10.1038/srep32286.

3.

Brain metastases management paradigm shift: A case report and review of the literature.

Refaat T, Sachdev S, Desai B, Bacchus I, Hatoum S, Lee P, Bloch O, Chandler JP, Kalapurakal J, Marymont MH.

Mol Clin Oncol. 2016 Apr;4(4):487-491.

4.

Supra-complete surgery via dual intraoperative visualization approach (DiVA) prolongs patient survival in glioblastoma.

Eyüpoglu IY, Hore N, Merkel A, Buslei R, Buchfelder M, Savaskan N.

Oncotarget. 2016 May 3;7(18):25755-68. doi: 10.18632/oncotarget.8367.

6.

The benefit of surgical resection in recurrent glioblastoma.

Vogelbaum MA.

Neuro Oncol. 2016 Apr;18(4):462-3. doi: 10.1093/neuonc/now004. No abstract available.

PMID:
26869588
7.

Neurocognitive Changes Associated With Surgical Resection of Left and Right Temporal Lobe Glioma.

Noll KR, Weinberg JS, Ziu M, Benveniste RJ, Suki D, Wefel JS.

Neurosurgery. 2015 Nov;77(5):777-85. doi: 10.1227/NEU.0000000000000987.

8.

A new functional classification system (FGA/B) with prognostic value for glioma patients.

Friedlein K, Bozhkov Y, Hore N, Merkel A, Sommer B, Brandner S, Buchfelder M, Savaskan NE, Eyüpoglu IY.

Sci Rep. 2015 Jul 21;5:12373. doi: 10.1038/srep12373.

PMID:
26197301
Free PMC Article
9.

Advances in the Surgical Management of Low-Grade Glioma.

Hollon T, Hervey-Jumper SL, Sagher O, Orringer DA.

Semin Radiat Oncol. 2015 Jul;25(3):181-8. doi: 10.1016/j.semradonc.2015.02.007. Review.

10.

Autologous fibrin sealant (Vivostat(®)) in the neurosurgical practice: Part I: Intracranial surgical procedure.

Graziano F, Certo F, Basile L, Maugeri R, Grasso G, Meccio F, Ganau M, Iacopino DG.

Surg Neurol Int. 2015 May 12;6:77. doi: 10.4103/2152-7806.156871.

11.

Efficacy of surgical treatment for brain metastasis in patients with non-small cell lung cancer.

Kim SY, Hong CK, Kim TH, Hong JB, Park CH, Chang YS, Kim HJ, Ahn CM, Byun MK.

Yonsei Med J. 2015 Jan;56(1):103-11. doi: 10.3349/ymj.2015.56.1.103.

12.

Incidence, Risk Factors and Consequences of Emergence Agitation in Adult Patients after Elective Craniotomy for Brain Tumor: A Prospective Cohort Study.

Chen L, Xu M, Li GY, Cai WX, Zhou JX.

PLoS One. 2014 Dec 10;9(12):e114239. doi: 10.1371/journal.pone.0114239.

13.

The future of glioblastoma therapy: synergism of standard of care and immunotherapy.

Patel MA, Kim JE, Ruzevick J, Li G, Lim M.

Cancers (Basel). 2014 Sep 29;6(4):1953-85. doi: 10.3390/cancers6041953. Review.

14.

The butterfly effect on glioblastoma: is volumetric extent of resection more effective than biopsy for these tumors?

Chaichana KL, Jusue-Torres I, Lemos AM, Gokaslan A, Cabrera-Aldana EE, Ashary A, Olivi A, Quinones-Hinojosa A.

J Neurooncol. 2014 Dec;120(3):625-34. doi: 10.1007/s11060-014-1597-9.

15.

Neurotoxicity associated with cancer therapy.

Lu Lee E, Westcarth L.

J Adv Pract Oncol. 2012 Jan;3(1):11-21. Review.

16.

Surgically acquired deficits and diffusion weighted MRI changes after glioma resection--a matched case-control study with blinded neuroradiological assessment.

Jakola AS, Berntsen EM, Christensen P, Gulati S, Unsgård G, Kvistad KA, Solheim O.

PLoS One. 2014 Jul 3;9(7):e101805. doi: 10.1371/journal.pone.0101805.

17.

Current trends in glioblastoma multiforme treatment: radiation therapy and immune checkpoint inhibitors.

Nicholas S, Mathios D, Ruzevick J, Jackson C, Yang I, Lim M.

Brain Tumor Res Treat. 2013 Apr;1(1):2-8. doi: 10.14791/btrt.2013.1.1.2. Review.

18.

5-Aminolevulinic acid fluorescence in high grade glioma surgery: surgical outcome, intraoperative findings, and fluorescence patterns.

Della Puppa A, Ciccarino P, Lombardi G, Rolma G, Cecchin D, Rossetto M.

Biomed Res Int. 2014;2014:232561. doi: 10.1155/2014/232561.

19.
20.

Towards a genomic definition of completeness of resection?

Vogelbaum MA.

Neuro Oncol. 2014 Jan;16(1):2-3. doi: 10.1093/neuonc/not231. No abstract available.

Items per page

Supplemental Content

Support Center